Method of Treating Atherosclerosis, Dyslipidemias And Related Conditions And Pharmaceutical Compositions

Details for Australian Patent Application No. 2011200986 (hide)

Owner Merck Frosst Canada Ltd Merck Sharp & Dohme Corp.

Inventors Cheng, Kang; Waters, Gerard; Metters, Kathleen; O'Neill, Gary

Agent A J Park

Pub. Number AU-A-2011200986

Parent 2004240597

Filing date 7 March 2011

Wipo publication date 31 March 2011

International Classifications

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/00 (2006.01)

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/437 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/538 (2006.01)

A61K 31/69 (2006.01) - Boron compounds

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

24 March 2011 Complete Application Filed

31 March 2011 Application Open to Public Inspection

  Published as AU-A-2011200986

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Frosst Canada Ltd; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011200987-Vacuum cleaners

2011200985-Apparatus, method and computer-readable storage medium for determining the ring-down time in a spectrometer system